Cargando...
Prevention of chemotherapy-induced nausea: the role of neurokinin-1 (NK(1)) receptor antagonists
Chemotherapy-induced nausea (CIN) has a significant negative impact on the quality of life of cancer patients. The use of 5-hydroxytryptamine-3 (5-HT(3)) receptor antagonists (RAs) has reduced the risk of vomiting, but (except for palonosetron) their effect on nausea, especially delayed nausea, is l...
Gardado en:
| Publicado en: | Support Care Cancer |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Springer Berlin Heidelberg
2017
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5378744/ https://ncbi.nlm.nih.gov/pubmed/28108820 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00520-017-3585-z |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|